Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes

<table>Inhibition of executive caspases cleavage by caspase inhibitors z-VAD-fmk (20 <i>μ</i>M) or Q-VD-OPh (10 <i>μ</i>M) in CML-T1 cells treated by 1 <i>μ</i>M DAC + 1 <i>μ</i>M SAHA for 48 h. </table>

BioMed Research International

fig3

Figure 3

Figure 3: Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes 

Figure 3 | Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes 